Updates
Dear Sirs, We enclose a communication pertaining to Health Canada approval. This is for your kind information and records.29-09-2017
29-09-2017
Updates
Sub: Intimation regarding closure of Trading Window Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Saturday, September 23, 2017 and the same shall remain closed till 48 hours after the announcement of the financial results for the quarter ending September 30, 2017 to the Stock Exchanges....21-09-2017
Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company is participating in the India Investor Summit organised by J.P. Morgan India Private Limited on September 20, 2017 in National Capital Region, India. Kindly find enclosed the details of investor/analyst meetings scheduled for the same....19-09-2017
Annual Report For The Financial Year Ended March 31, 2017
Pursuant to the provisions of Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the Annual Report along with Sustainability Report of the Company for the financial year ended March 31, 2017. This is for your information and records.11-09-2017
Analyst / Investor Meet Intimation
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company is participating in the 13th Annual Global Investor Conference, 2017 organised by Motilal Oswal Securities Limited on September 5, 2017 in Mumbai. Kindly find enclosed the details of investor/analyst meetings scheduled for the same....04-09-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd30-08-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jubilant Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-08-2017
Scrutinizer's Report
Jubilant Life Sciences Limited - Scrutinizer's Report and Voting Results of 39th Annual General Meeting29-08-2017
Outcome of AGM
Proceedings of 39th Annual General Meeting of Jubilant Life Sciences Limited29-08-2017